An Evolving Frontier: Targeting Immune Dysregulation in Immune Thrombocytopenia
These insights have fundamentally reshaped the pathophysiological model of the disease and have driven the development of targeted therapeutic strategies that address multiple underlying mechanisms rather than platelet destruction alone.
Read Article